Women’s health innovation is accelerating. From AI enabled diagnostics to personalised care pathways, FemTech is reshaping how products are built, tested and adopted. At the same time, regulation, data protection and investment scrutiny are growing, which raises new questions for founders, investors and corporates across the sector.
Over the coming weeks, we’ll release an eight part article series from our cross sector Life Sciences, Technology and Consumer Goods teams – leading up to our flagship London event on 12 May 2026, with a final article to follow after the event.
Available Articles
FemTech – “Female Technology” – has emerged rapidly in recent years as a distinct category in the health and technology landscape, reflecting a long overdue recognition that historical product development has often failed to meet women’s needs.
26 March 2026
Historically, women's health has received less attention and funding in medical research and health related technological development. It is widely recognised that not enough focus has been placed on women-specific issues such as menstrual health, fertility, pregnancy loss and menopause, amongst many others.
10 April 2026
